Evidence map›Paper›PMID 38046000›Full record

ArticleClinical kidney journal2023

The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease.

Megan Astley, Fergus J Caskey, Marie Evans, Claudia Torino, Maciej Szymczak, Christiane Drechsler, Maria Pippias, Esther de Rooij, Gaetana Porto, Vianda S Stel and 5 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Kidney replacement therapy for men and women according to the ERA Registry and the USRDS.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Kynurenine Pathway after Kidney Transplantation: Friend or Foe?International journal of molecular sciences · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Megan AstleyAmsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.
Fergus J CaskeyPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Marie EvansRenal Unit, Department of Clinical Intervention and Technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-8650-5795
Claudia TorinoIFC-CNR, Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
Maciej SzymczakDepartment of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland.
Christiane DrechslerDivision of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
Maria PippiasPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Esther de RooijDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Gaetana PortoG.O.M., Bianchi Melacrino Morelli, Reggio Calabria, Italy.
Vianda S StelAmsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.
Friedo W DekkerDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Christoph WannerDivision of Nephrology, University Hospital of Würzburg, Würzburg, Germany.ORCID https://orcid.org/0000-0001-9507-5301
Kitty J JagerAmsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.
Nicholas C ChesnayeAmsterdam UMC location University of Amsterdam, ERA Registry, Medical Informatics, Amsterdam, the Netherlands.
EQUAL study investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with chronic kidney disease (CKD) are at a higher risk of major adverse cardiovascular events (MACE) compared with the general population, but gender differences in this risk, especially in older adults, are not fully known. We aim to identify gender differences in the risk of MACE in older European CKD patients, and explore factors that may explain these differences. Methods: The European Quality study (EQUAL) is a prospective study on stage 4-5 CKD patients, ≥65 years old, not on dialysis, from Germany, Italy, the Netherlands, Poland, Sweden and the UK. Cox regression and cumulative incidence competing risk curves were used to identify gender differences in MACE risks. Mediation analysis was used to identify variables which may explain risk differences between men and women. Results: A total of 417 men out of 1134 (37%) and 185 women out of 602 women (31%) experienced at least one MACE, over a follow-up period of 5 years. Women had an 18% lower risk of first MACE compared with men (hazard ratio 0.82; 95% confidence interval 0.69-0.97; Conclusions: In a cohort of older adults with advanced CKD, women had lower risks of MACE. These risk differences were partially explained by pre-existing cardiometabolic comorbidities and cardiovascular risk factors.

Indexed as

cardiovascular eventschronic kidney diseasegender differencesolder adultsrisk differences

Identifiers

PMID38046000
PMCPMC10689190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.